Article info
PDFNeuro-inflammation
Research paper
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
- Correspondence to Professor Ingo Kleiter, Department of Neurology, St. Josef Hospital, Ruhr University Bochum, Gudrunstr. 56, Bochum 44791, Germany; ingo.kleiter{at}rub.de
Citation
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
Publication history
- Received January 8, 2017
- Revised March 13, 2017
- Accepted March 20, 2017
- First published June 1, 2017.
Online issue publication
July 20, 2017
Article Versions
- Previous version (20 July 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/